OrganOx Funding Round

7/17/2023

Venture Equity

$32,210,000

Undisclosed

The company intends to use the funds to expand its commercial footprint, build new manufacturing facilities, and conduct a broad array of post-market clinical evaluations.

Private & Independent

Medical Devices & Instruments

Oxford Science Park Sherrington Building, Magdalen Centre, R
Oxford, England, OX4 4GA
UK

OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers for up to 24 hours prior to transplant. Our Chief Medical Officer, Professor Peter Friend, and colleagues heralded the start of the normothermic machine perfusion revolution in liver transplantation with a first publication in 2002.2 Since then, over 50 publications have supported the patented OrganOx technology demonstrating its advantages over conventional cold storage and cold perfusion technologies.